Papers
1
Total Citations
26
H-Index
1
About
Dr. Danning Wu is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques in pancreatic surgery, with a particular emphasis on robotic approaches. Her most cited work, a 2022 meta-analysis comparing robotic versus open pancreaticoduodenectomy, represents a landmark contribution to the field. This comprehensive study synthesized evidence from multiple cohort studies to evaluate perioperative outcomes in both general patient populations and those with pancreatic cancer. By systematically analyzing critical metrics—including operative time, blood loss, R0 resection rates, lymph node harvest, and overall complication rates—Dr. Wu provided surgeons with evidence-based guidance on the safety and efficacy of robotic approaches. Her work has garnered 26 citations, reflecting its significant impact on surgical practice and clinical decision-making. Through this rigorous comparative analysis, Dr. Wu has helped clarify the role of robotic surgery in pancreaticoduodenectomy, addressing key questions about oncologic adequacy and perioperative safety. Her research continues to shape the evolution of pancreatic cancer surgery, offering valuable insights for surgeons seeking to optimize patient outcomes through technological innovation.
Research Focus
Key Achievements
Top Papers
- 1